Forgoing Treatment at the End of Life in 6 European Countries

Authors:
  • TNTore Nilstun
    Tore Nilstun
  • JBJohan Bilsen
    Johan Bilsen
  • MNMichael Norup
    Michael Norup
  • GMGuido Miccinesi
    Guido Miccinesi
  • JDJohannes J M Van Delden
    Johannes J M Van Delden
  • KFKarin Faisst
    Karin Faisst
  • AHAgnes Van Der Heide
    Agnes Van Der Heide
  • ECEuropean End-of-Life Consortium
    European End-of-Life Consortium

Abstract
Modern medicine provides unprecedented opportunities in diagnostics and treatment to save and sustain life, which, in principle, nobody wants to do without. However, confronted with patients in the last stage of disease, the question arises whether it is sometimes justified or even advisable not to use all possible life-sustaining measures. Some studies1-5 have found that many patients wish particular life-sustaining treatment to be withheld or withdrawn. Other studies6-9 have shown that physicians dispense with various life-sustaining treatments when faced with terminally ill patients. However, when considering real end-of-life situations, the validity of studies based on hypothetical scenarios is less clear.3,4 Furthermore, most of these studies are restricted to specific settings (eg, hospital, nursing home, or intensive care unit)1,4,6-9 or patient groups (eg, patients with cancer or those with renal failure).2,5 Given the different patient populations and/or study designs, it is often hard to compare results.

This publication has 17 references indexed in Scilit: